{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T09:11:54Z","timestamp":1678698714831},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T00:00:00Z","timestamp":1364256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12072-013-9427-2","type":"journal-article","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T13:54:05Z","timestamp":1364219645000},"page":"369-376","source":"Crossref","is-referenced-by-count":5,"title":["Role of anticoagulant therapy in liver disease"],"prefix":"10.1007","volume":"7","author":[{"given":"Elisabeth P. C.","family":"Plompen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeoffrey N. L.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry L. A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,26]]},"reference":[{"key":"9427_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/BF01313579","volume":"26","author":"K Ewe","year":"1981","unstructured":"Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981;26:388\u2013393","journal-title":"Dig Dis Sci"},{"key":"9427_CR2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/j.1537-2995.2005.00546.x","volume":"45","author":"JB Segal","year":"2005","unstructured":"Segal JB, Dzik WH. Transfusion medicine\/hemostasis clinical trials N. paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005;45:1413\u20131425","journal-title":"Transfusion"},{"key":"9427_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1053\/j.gastro.2004.07.015","volume":"127","author":"J Bosch","year":"2004","unstructured":"Bosch J, Thabut D, Bendtsen F, D\u2019Amico G, Albillos A, Gonzalez Abraldes J, Fabricius S, et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 2004;127:1123\u20131130","journal-title":"Gastroenterology"},{"key":"9427_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/lt.20458","volume":"11","author":"RM Planinsic","year":"2005","unstructured":"Planinsic RM, van der Meer J, Testa G, Grande L, Candela A, Porte RJ, Ghobrial RM, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl 2005;11:895\u2013900","journal-title":"Liver Transpl"},{"key":"9427_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ajg.2008.34","volume":"104","author":"KK Sogaard","year":"2009","unstructured":"Sogaard KK, Horvath-Puho E, Gronbaek H, Jepsen P, Vilstrup H, Sorensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009;104:96\u2013101","journal-title":"Am J Gastroenterol"},{"key":"9427_CR6","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","volume":"40","author":"L Amitrano","year":"2004","unstructured":"Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004;40:736\u2013741","journal-title":"J Hepatol"},{"key":"9427_CR7","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","volume":"137","author":"A Tripodi","year":"2009","unstructured":"Tripodi A, Primignani M, Chantarangkul V, Dell\u2019Era A, Clerici M, de Franchis R, Colombo M, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009;137:2105\u20132111","journal-title":"Gastroenterology"},{"key":"9427_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hep.21231","volume":"44","author":"T Lisman","year":"2006","unstructured":"Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006;44:53\u201361","journal-title":"Hepatology"},{"key":"9427_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2141.2009.07833.x","volume":"147","author":"A Tripodi","year":"2009","unstructured":"Tripodi A, Chantarangkul V, Mannucci PM. Acquired coagulation disorders: revisited using global coagulation\/anticoagulation testing. Br J Haematol 2009;147:77\u201382","journal-title":"Br J Haematol"},{"key":"9427_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/hep.23653","volume":"52","author":"A Tripodi","year":"2010","unstructured":"Tripodi A, Primignani M, Lemma L, Chantarangkul V, Dell\u2019Era A, Iannuzzi F, Aghemo A, et al. Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology 2010;52:249\u2013255","journal-title":"Hepatology"},{"key":"9427_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/hep.21266","volume":"44","author":"A Tripodi","year":"2006","unstructured":"Tripodi A, Primignani M, Chantarangkul V, Clerici M, Dell\u2019Era A, Fabris F, Salerno F, et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 2006;44:440\u2013445","journal-title":"Hepatology"},{"key":"9427_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/hep.20569","volume":"41","author":"A Tripodi","year":"2005","unstructured":"Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannuccio Mannucci P. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005;41:553\u2013558","journal-title":"Hepatology"},{"key":"9427_CR13","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1111\/j.1538-7836.2010.03937.x","volume":"8","author":"A Gatt","year":"2010","unstructured":"Gatt A, Riddell A, Calvaruso V, Tuddenham EG, Makris M, Burroughs AK. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost 2010;8:1994\u20132000","journal-title":"J Thromb Haemost"},{"key":"9427_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","volume":"53","author":"R Franchis de","year":"2010","unstructured":"de Franchis R, Baveno VF. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762\u2013768","journal-title":"J Hepatol"},{"key":"9427_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","volume":"151","author":"S Darwish Murad","year":"2009","unstructured":"Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009;151:167\u2013175","journal-title":"Ann Intern Med"},{"key":"9427_CR16","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/hep.22772","volume":"49","author":"LD DeLeve","year":"2009","unstructured":"DeLeve LD, Valla DC, Garcia-Tsao G, American Association for the Study Liver D. Vascular disorders of the liver. Hepatology 2009;49:1729\u20131764","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"9427_CR17","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/S0168-8278(12)60004-X","volume":"56","author":"A Plessier","year":"2012","unstructured":"Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56(Suppl 1):S25\u201338","journal-title":"J Hepatol"},{"key":"9427_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/hep.510300125","volume":"30","author":"G Zeitoun","year":"1999","unstructured":"Zeitoun G, Escolano S, Hadengue A, Azar N, El Younsi M, Mallet A, Boudet MJ, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999;30:84\u201389","journal-title":"Hepatology"},{"key":"9427_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S0168-8278(03)00323-4","volume":"39","author":"P Langlet","year":"2003","unstructured":"Langlet P, Escolano S, Valla D, Coste-Zeitoun D, Denie C, Mallet A, Levy VG, et al. Clinicopathological forms and prognostic index in Budd-Chiari syndrome. J Hepatol 2003;39:496\u2013501","journal-title":"J Hepatol"},{"key":"9427_CR20","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/hep.20064","volume":"39","author":"S Darwish Murad","year":"2004","unstructured":"Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, van Hoek B, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004;39:500\u2013508","journal-title":"Hepatology"},{"key":"9427_CR21","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/hep.21354","volume":"44","author":"A Plessier","year":"2006","unstructured":"Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006;44:1308\u20131316","journal-title":"Hepatology"},{"key":"9427_CR22","doi-asserted-by":"crossref","unstructured":"Plessier ACY, Boudaoud L. Budd-chiari syndrome (BCS) and heparin induced thrombocytopenia (HIT). J Hepatol 2006;44","DOI":"10.1016\/S0168-8278(06)80229-1"},{"key":"9427_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000280466","volume":"123","author":"ML Randi","year":"2010","unstructured":"Randi ML, Tezza F, Scapin M, Duner E, Scarparo P, Scandellari R, Fabris F. Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis. Acta Haematol 2010;123:140\u20135","journal-title":"Acta Haematol"},{"key":"9427_CR24","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/S0168-8278(08)60284-6","volume":"48","author":"Primignani Mea","year":"2008","unstructured":"Mea Primignani. High incidence of heparin induced thrombocytopenia (HIT) in splanchnic vein thrombosis treated with low molecular weight heparin (LMWH). J Hepatol 2008;48:S113","journal-title":"J Hepatol"},{"key":"9427_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jhep.2010.06.019","volume":"54","author":"PE Rautou","year":"2011","unstructured":"Rautou PE, Douarin L, Denninger MH, Escolano S, Lebrec D, Moreau R, Vidaud M, et al. Bleeding in patients with Budd-Chiari syndrome. J Hepatol 2011;54:56\u201363","journal-title":"J Hepatol"},{"key":"9427_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jhep.2003.09.028","volume":"40","author":"S Sharma","year":"2004","unstructured":"Sharma S, Texeira A, Texeira P, Elias E, Wilde J, Olliff SP. Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol 2004;40:172\u2013180","journal-title":"J Hepatol"},{"key":"9427_CR27","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1160\/TH08-01-0015","volume":"100","author":"JH Smalberg","year":"2008","unstructured":"Smalberg JH, Spaander MV, Jie KS, Pattynama PM, van Buuren HR, van den Berg B, Janssen HL, et al. Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis. Thromb Haemost 2008;100:1084\u20131088","journal-title":"Thromb Haemost"},{"key":"9427_CR28","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","volume":"12","author":"M Ogren","year":"2006","unstructured":"Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006;12:2115\u20132119","journal-title":"World J Gastroenterol"},{"key":"9427_CR29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1053\/jhep.2000.16597","volume":"32","author":"B Condat","year":"2000","unstructured":"Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000;32:466\u2013470","journal-title":"Hepatology"},{"key":"9427_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/hep.23259","volume":"51","author":"A Plessier","year":"2010","unstructured":"Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010;51:210\u2013218","journal-title":"Hepatology"},{"key":"9427_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/01.RVI.0000156265.79960.86","volume":"16","author":"M Hollingshead","year":"2005","unstructured":"Hollingshead M, Burke CT, Mauro MA, Weeks SM, Dixon RG, Jaques PF. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol 2005;16:651\u2013661","journal-title":"J Vasc Interv Radiol"},{"key":"9427_CR32","first-page":"2098","volume":"50","author":"P Malkowski","year":"2003","unstructured":"Malkowski P, Pawlak J, Michalowicz B, Szczerban J, Wroblewski T, Leowska E, Krawczyk M. Thrombolytic treatment of portal thrombosis. Hepatogastroenterology 2003;50:2098\u20132100","journal-title":"Hepatogastroenterology"},{"key":"9427_CR33","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1111\/j.1572-0241.2007.01477.x","volume":"102","author":"L Amitrano","year":"2007","unstructured":"Amitrano L, Guardascione MA, Scaglione M, Pezzullo L, Sangiuliano N, Armellino MF, Manguso F, et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007;102:2464\u20132470","journal-title":"Am J Gastroenterol"},{"key":"9427_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1053\/gast.2001.21209","volume":"120","author":"B Condat","year":"2001","unstructured":"Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001;120:490\u2013497","journal-title":"Gastroenterology"},{"key":"9427_CR35","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1538-7836.2006.02264.x","volume":"5","author":"M Ogren","year":"2007","unstructured":"Ogren M, Bergqvist D, Bjorck M, Acosta S, Sternby NH. High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: a population study based on 23,796 consecutive autopsies. J Thromb Haemost 2007;5:198\u2013200","journal-title":"J Thromb Haemost"},{"key":"9427_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cgh.2006.09.030","volume":"5","author":"DW Orr","year":"2007","unstructured":"Orr DW, Harrison PM, Devlin J, Karani JB, Kane PA, Heaton ND, O\u2019Grady JG, et al. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up. Clin Gastroenterol Hepatol 2007;5:80\u201386","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9427_CR37","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","volume":"51","author":"MA Zocco","year":"2009","unstructured":"Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009;51:682\u2013689","journal-title":"J Hepatol"},{"key":"9427_CR38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gut.2004.042796","volume":"54","author":"C Francoz","year":"2005","unstructured":"Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005;54:691\u2013697","journal-title":"Gut"},{"key":"9427_CR39","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/hep.1840160515","volume":"16","author":"T Nonami","year":"1992","unstructured":"Nonami T, Yokoyama I, Iwatsuki S, Starzl TE. The incidence of portal vein thrombosis at liver transplantation. Hepatology 1992;16:1195\u20131198","journal-title":"Hepatology"},{"key":"9427_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/hep.510310213","volume":"31","author":"L Amitrano","year":"2000","unstructured":"Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D\u2019Andrea G, Marmo R, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000;31:345\u2013348","journal-title":"Hepatology"},{"key":"9427_CR41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","volume":"44","author":"L Amitrano","year":"2010","unstructured":"Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, Giovine S, Romano L, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2010;44:448\u2013451","journal-title":"J Clin Gastroenterol"},{"key":"9427_CR42","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","volume":"10","author":"MG Delgado","year":"2012","unstructured":"Delgado MG, Seijo S, Yepes I, Achecar L, Catalina MV, Garcia-Criado A, Abraldes JG, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2012;10:776\u2013783","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9427_CR43","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","volume":"32","author":"M Senzolo","year":"2012","unstructured":"Senzolo M, MS T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D. Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012;32:919\u2013927","journal-title":"Liver Int"},{"key":"9427_CR44","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/hep.24422","volume":"54","author":"JN Schouten","year":"2011","unstructured":"Schouten JN, Garcia-Pagan JC, Valla DC, Janssen HL. Idiopathic noncirrhotic portal hypertension. Hepatology 2011;54:1071\u20131081","journal-title":"Hepatology"},{"key":"9427_CR45","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1365-2036.2012.05112.x","volume":"35","author":"JN Schouten","year":"2012","unstructured":"Schouten JN, Nevens F, Hansen B, Laleman W, van den Born M, Komuta M, Roskams T, et al. Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther 2012;35:1424\u20131433","journal-title":"Aliment Pharmacol Ther"},{"key":"9427_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/gut.51.2.275","volume":"51","author":"S Hillaire","year":"2002","unstructured":"Hillaire S, Bonte E, Denninger MH, Casadevall N, Cadranel JF, Lebrec D, Valla D, et al. Idiopathic noncirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002;51:275\u2013280","journal-title":"Gut"},{"key":"9427_CR47","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/apt.12049","volume":"36","author":"JN Schouten","year":"2012","unstructured":"Schouten JN, Van der Ende ME, Koeter T, Rossing HH, Komuta M, Verheij J, van der Valk M, et al. Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension. Aliment Pharmacol Ther 2012;36:875\u2013885","journal-title":"Aliment Pharmacol Ther"},{"key":"9427_CR48","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/ajg.2009.165","volume":"104","author":"PE Chang","year":"2009","unstructured":"Chang PE, Miquel R, Blanco JL, Laguno M, Bruguera M, Abraldes JG, Bosch J, et al. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol 2009;104:1707\u20131714","journal-title":"Am J Gastroenterol"},{"key":"9427_CR49","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/hep.22192","volume":"47","author":"DC Valla","year":"2008","unstructured":"Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology 2008;47:1384\u20131393","journal-title":"Hepatology"},{"key":"9427_CR50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jhep.2010.07.038","volume":"54","author":"D Cazals-Hatem","year":"2011","unstructured":"Cazals-Hatem D, Hillaire S, Rudler M, Plessier A, Paradis V, Condat B, Francoz C, et al. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol 2011;54:455\u2013461","journal-title":"J Hepatol"},{"key":"9427_CR51","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","volume":"37","author":"H Imran","year":"2006","unstructured":"Imran H, Tleyjeh IM, Zirakzadeh A, Rodriguez V, Khan SP. Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. Bone Marrow Transpl 2006;37:677\u2013686","journal-title":"Bone Marrow Transplant"},{"key":"9427_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","volume":"10","author":"Y Chalandon","year":"2004","unstructured":"Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P, Helg C, et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transpl 2004;10:347\u2013354","journal-title":"Biol Blood Marrow Transplant"},{"key":"9427_CR53","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","volume":"111","author":"R Chopra","year":"2000","unstructured":"Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C, Neumeister P, et al. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol 2000;111:1122\u20131129","journal-title":"Br J Haematol"},{"key":"9427_CR54","first-page":"737","volume":"92","author":"PG Richardson","year":"1998","unstructured":"Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D, Kinchla NM, et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998;92:737\u2013744","journal-title":"Blood"},{"key":"9427_CR55","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, Elias AD, et al. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002;100:4337\u20134343","journal-title":"Blood"},{"key":"9427_CR56","first-page":"1232","volume":"21","author":"IR Wanless","year":"1995","unstructured":"Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995;21:1232\u20131237","journal-title":"Hepatology"},{"key":"9427_CR57","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.clinre.2011.03.011","volume":"35","author":"QM Anstee","year":"2011","unstructured":"Anstee QM, Dhar A, Thursz MR. The role of hypercoagulability in liver fibrogenesis. Clin Res Hepatol Gastroenterol 2011;35:526\u2013533","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"9427_CR58","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/hep.20054","volume":"39","author":"S Fiorucci","year":"2004","unstructured":"Fiorucci S, Antonelli E, Distrutti E, Severino B, Fiorentina R, Baldoni M, Caliendo G, et al. PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation. Hepatology 2004;39:365\u2013375","journal-title":"Hepatology"},{"key":"9427_CR59","doi-asserted-by":"publisher","first-page":"G226","DOI":"10.1152\/ajpgi.00444.2007","volume":"294","author":"A Rullier","year":"2008","unstructured":"Rullier A, Gillibert-Duplantier J, Costet P, Cubel G, Haurie V, Petibois C, Taras D, et al. Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2008;294:G226\u2013235","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9427_CR60","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/j.1440-1746.2007.05220.x","volume":"23","author":"A Martinelli","year":"2008","unstructured":"Martinelli A, Knapp S, Anstee Q, Worku M, Tommasi A, Zucoloto S, Goldin R, et al. Effect of a thrombin receptor (protease-activated receptor 1, PAR-1) gene polymorphism in chronic hepatitis C liver fibrosis. J Gastroenterol Hepatol 2008;23:1403\u20131409","journal-title":"J Gastroenterol Hepatol"},{"key":"9427_CR61","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/gut.47.6.845","volume":"47","author":"TT Yee","year":"2000","unstructured":"Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut 2000;47:845\u2013851","journal-title":"Gut"},{"key":"9427_CR62","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/j.1572-0241.2007.01223.x","volume":"102","author":"N Assy","year":"2007","unstructured":"Assy N, Pettigrew N, Lee SS, Chaudhary RK, Johnston J, Minuk GY. Are chronic hepatitis C viral infections more benign in patients with hemophilia? Am J Gastroenterol 2007;102:1672\u20131676","journal-title":"Am J Gastroenterol"},{"key":"9427_CR63","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","volume":"52","author":"M Wright","year":"2003","unstructured":"Wright M, Goldin R, Hellier S, Knapp S, Frodsham A, Hennig B, Hill A, et al. Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut 2003;52:1206\u20131210","journal-title":"Gut"},{"key":"9427_CR64","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.3748\/wjg.v17.i45.5007","volume":"17","author":"N Maharshak","year":"2011","unstructured":"Maharshak N, Halfon P, Deutsch V, Peretz H, Berliner S, Fishman S, Zelber-Sagi S, et al. Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation. World J Gastroenterol 2011;17:5007\u20135013","journal-title":"World J Gastroenterol"},{"key":"9427_CR65","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/gut.52.3.404","volume":"52","author":"GV Papatheodoridis","year":"2003","unstructured":"Papatheodoridis GV, Papakonstantinou E, Andrioti E, Cholongitas E, Petraki K, Kontopoulou I, Hadziyannis SJ. Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis. Gut 2003;52:404\u2013409","journal-title":"Gut"},{"key":"9427_CR66","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1572-0241.2004.04092.x","volume":"99","author":"A Poujol-Robert","year":"2004","unstructured":"Poujol-Robert A, Rosmorduc O, Serfaty L, Coulet F, Poupon R, Robert A. Genetic and acquired thrombotic factors in chronic hepatitis C. Am J Gastroenterol 2004;99:527\u2013531","journal-title":"Am J Gastroenterol"},{"key":"9427_CR67","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10620-006-9121-5","volume":"51","author":"A Poujol-Robert","year":"2006","unstructured":"Poujol-Robert A, Boelle PY, Wendum D, Poupon R, Robert A. Association between ABO blood group and fibrosis severity in chronic hepatitis C infection. Dig Dis Sci 2006;51:1633\u20131636","journal-title":"Dig Dis Sci"},{"key":"9427_CR68","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jhep.2009.06.023","volume":"51","author":"GV Papatheodoridis","year":"2009","unstructured":"Papatheodoridis GV, Chrysanthos N, Cholongitas E, Pavlou E, Apergis G, Tiniakos DG, Andrioti E, et al. Thrombotic risk factors and liver histologic lesions in nonalcoholic fatty liver disease. J Hepatol 2009;51:931\u2013938","journal-title":"J Hepatol"},{"key":"9427_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.phrs.2004.04.009","volume":"51","author":"OM Abdel-Salam","year":"2005","unstructured":"Abdel-Salam OM, Baiuomy AR, Ameen A, Hassan NS. A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat. Pharmacol Res 2005;51:59\u201367","journal-title":"Pharmacol Res"},{"key":"9427_CR70","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jhep.2006.08.023","volume":"46","author":"W Abe","year":"2007","unstructured":"Abe W, Ikejima K, Lang T, Okumura K, Enomoto N, Kitamura T, Takei Y, et al. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. J Hepatol 2007;46:286\u2013294","journal-title":"J Hepatol"},{"key":"9427_CR71","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s10620-006-9595-1","volume":"52","author":"N Assy","year":"2007","unstructured":"Assy N, Hussein O, Khalil A, Luder A, Szvalb S, Paizi M, Spira G. The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis. Dig Dis Sci 2007;52:1187\u20131193","journal-title":"Dig Dis Sci"},{"key":"9427_CR72","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1136\/gut.2003.032136","volume":"53","author":"JG Duplantier","year":"2004","unstructured":"Duplantier JG, Dubuisson L, Senant N, Freyburger G, Laurendeau I, Herbert JM, Desmouliere A, et al. A role for thrombin in liver fibrosis. Gut 2004;53:1682\u20131687","journal-title":"Gut"},{"key":"9427_CR73","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1538-7836.2008.03015.x","volume":"6","author":"QM Anstee","year":"2008","unstructured":"Anstee QM, Goldin RD, Wright M, Martinelli A, Cox R, Thursz MR. Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies. J Thromb Haemost 2008;6:1336\u20131343","journal-title":"J Thromb Haemost"},{"key":"9427_CR74","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3748\/wjg.v9.i7.1611","volume":"9","author":"J Shi","year":"2003","unstructured":"Shi J, Hao JH, Ren WH, Zhu JR. Effects of heparin on liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol 2003;9:1611\u20131614","journal-title":"World J Gastroenterol"},{"issue":"1253\u20131260","key":"9427_CR75","first-page":"e1254","volume":"143","author":"E Villa","year":"2012","unstructured":"Villa E, Camma C, Marietta M, Luongo M, Critelli R, Colopi S, Tata C, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012;143(1253\u20131260):e1254","journal-title":"Gastroenterology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-013-9427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-013-9427-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-013-9427-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-013-9427-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T10:04:01Z","timestamp":1644660241000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-013-9427-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,26]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9427"],"URL":"https:\/\/doi.org\/10.1007\/s12072-013-9427-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,26]]}}}